Job Recruitment Website - Social security inquiry - What is the national policy on chronic diseases?

What is the national policy on chronic diseases?

Legal analysis: The National Medical Insurance Bureau, together with the Ministry of Finance, the Health and Health Commission and the Food and Drug Administration, issued the Guiding Opinions on Improving the Drug Security Mechanism for Outpatients with Hypertension and Diabetes among Urban and Rural Residents. The "Opinions" clarified four safeguard measures: First, it clarified that the target of protection is patients with hypertension and diabetes who participate in medical insurance for urban and rural residents and take medicines. Second, it is clear that the scope of drug protection is antihypertensive drugs and hypoglycemic drugs in the national basic medical insurance drug list, giving priority to drugs in the list, national essential drugs, varieties that have passed the consistency evaluation, and centralized procurement of selected drugs. The third is to clarify the level of protection. Relying on the secondary and below designated primary medical institutions, the outpatient expenses of blood pressure and blood sugar lowering drugs for patients with "two diseases" are paid by the overall fund, and the proportion of payment within the policy scope reaches more than 50%. All localities should make reasonable payment policies on the basis of finding out the actual situation of the quantity, quantity and amount of drugs used in the "two diseases" outpatient service. The fourth is to do a good job of policy convergence. For patients with "two diseases" who have been included in the scope of chronic diseases and special diseases in outpatient clinics, we will continue to implement the existing policies to ensure that the treatment level of the masses will not be reduced. It is necessary to avoid repeated reimbursement and repeated enjoyment of benefits. It is necessary to make a good connection with hospitalization security, further standardize admission standards, and promote rational diagnosis and treatment and scientific treatment.

Legal basis: The Guiding Opinions on Improving the Medication Guarantee Mechanism for Outpatients with Hypertension and Diabetes in Urban and Rural Residents proposes that patients with hypertension and diabetes who have participated in the basic medical insurance for urban and rural residents should be included in the outpatient medical insurance catalogue, and the reimbursement rate should reach more than 50%. At the same time, it is required to continue to implement the existing policies for patients who have been included in the scope of outpatient chronic diseases and special diseases to ensure that the level of treatment is not reduced. Promote the price reduction and quality improvement of domestic antihypertensive drugs and hypoglycemic drugs. Accelerate centralized bidding and procurement, expand the scope of procurement, reduce the cost of drug procurement, implement the long prescription system, and take various measures to reduce the burden on patients.